Cann Group Ltd
CVJ
Company Profile
Business description
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.
Contact
262-276 Lorimer Street
Ground Floor
Port MelbourneVIC3207
AUST: +61 390957088
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2026
Employees
40
Stocks News & Analysis
stocks
Our view on oil prices after Maduro is deposed
We’ve revisited our oil price assumptions after the news from Venezuela.
stocks
Nvidia: Full steam ahead with an impressive array of announcements at CES 2026
Our view of Nvidia at the current share price.
stocks
Cheapest ASX member of our Best Idea’s list
This share is trading at the lowest price to fair value of the 14 companies on the list.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,996.90 | 78.80 | -0.87% |
| CAC 40 | 8,242.73 | 31.23 | 0.38% |
| DAX 40 | 24,867.59 | 1.10 | -0.00% |
| Dow JONES (US) | 49,183.99 | 206.81 | 0.42% |
| FTSE 100 | 10,131.93 | 127.36 | 1.27% |
| HKSE | 26,710.45 | 363.21 | 1.38% |
| NASDAQ | 23,509.42 | 113.60 | 0.49% |
| Nikkei 225 | 52,518.08 | 685.28 | 1.32% |
| NZX 50 Index | 13,663.58 | 76.35 | 0.56% |
| S&P 500 | 6,932.20 | 30.15 | 0.44% |
| S&P/ASX 200 | 8,682.80 | 88.50 | -1.01% |
| SSE Composite Index | 4,083.67 | 60.25 | 1.50% |